Skip to main navigation Skip to search Skip to main content

Phase 3, Randomized, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Multiple Myeloma (RRMM) - ALUMMINATE RRMM

Project: Research

Project Details

StatusFinished
Effective start/end date20/05/24 → 19/05/26

Keywords

  • Clinical Trials
  • CA058-1019

Clinical Trial Phase

  • Phase III (a & b)